01:37 PM EDT, 03/20/2024 (MT Newswires) -- Vigil Neuroscience ( VIGL ) said Wednesday that it appointed Petra Kaufmann as chief medical officer, succeeding Christopher Silber.
Kaufmann was previously chief medical officer at Affinia Therapeutics, Vigil said.
Vigil shares were up 3.8% in recent trading.
Price: 3.05, Change: +0.11, Percent Change: +3.85